Literature DB >> 34192214

Gas Plasma Technology-An Asset to Healthcare During Viral Pandemics Such as the COVID-19 Crisis?

Sander Bekeschus1,2, Axel Kramer3, Elisabetta Suffredini4, Thomas von Woedtke1,5, Vittorio Colombo6.   

Abstract

The COVID-19 crisis profoundly disguised the vulnerability of human societies and healthcare systems in the situation of a pandemic. In many instances, it became evident that the quick and safe reduction of viral load and spread is the foremost principle in the successful management of such a pandemic. However, it became also clear that many of the established routines in healthcare are not always sufficient to cope with the increased demand for decontamination procedures of items, healthcare products, and even infected tissues. For the last 25 years, the use of gas plasma technology has sparked a tremendous amount of literature on its decontaminating properties, especially for heat-labile targets, such as polymers and tissues, where chemical decontamination often is not appropriate. However, while the majority of earlier work focused on bacteria, only relatively few reports are available on the inactivation of viruses. We here aim to provide a perspective for the general audience of the chances and opportunities of gas plasma technology for supporting healthcare during viral pandemics such as the COVID-19 crisis. This includes possible real-world plasma applications, appropriate laboratory viral test systems, and critical points on the technical and safety requirements of gas plasmas for virus inactivation. This work is licensed under a Creative Commons Attribution 4.0 License. For more information, see https://creativecommons.org/licenses/by/4.0/.

Entities:  

Keywords:  Airborne virus; DBD; cold atmospheric pressure plasma; decontamination; plasma jet; transmission

Year:  2020        PMID: 34192214      PMCID: PMC8043491          DOI: 10.1109/TRPMS.2020.3002658

Source DB:  PubMed          Journal:  IEEE Trans Radiat Plasma Med Sci        ISSN: 2469-7303


  6 in total

Review 1.  H2A.X Phosphorylation in Oxidative Stress and Risk Assessment in Plasma Medicine.

Authors:  Clarissa S Schütz; Matthias B Stope; Sander Bekeschus
Journal:  Oxid Med Cell Longev       Date:  2021-12-13       Impact factor: 6.543

Review 2.  Combining Nanotechnology and Gas Plasma as an Emerging Platform for Cancer Therapy: Mechanism and Therapeutic Implication.

Authors:  Milad Rasouli; Nadia Fallah; Sander Bekeschus
Journal:  Oxid Med Cell Longev       Date:  2021-10-27       Impact factor: 6.543

3.  Decontamination of High-Efficiency Mask Filters From Respiratory Pathogens Including SARS-CoV-2 by Non-thermal Plasma.

Authors:  Klára Obrová; Eva Vaňková; Michal Sláma; Jan Hodek; Josef Khun; Lucie Ulrychová; Filomena Nogueira; Triin Laos; Isabella Sponseiler; Petra Kašparová; Anna Machková; Jan Weber; Vladimír Scholtz; Thomas Lion
Journal:  Front Bioeng Biotechnol       Date:  2022-02-14

4.  Plasma bioscience for medicine, agriculture and hygiene applications.

Authors:  Eun Ha Choi; Nagendra Kumar Kaushik; Young June Hong; Jun Sup Lim; Jin Sung Choi; Ihn Han
Journal:  J Korean Phys Soc       Date:  2022-03-04       Impact factor: 0.657

Review 5.  The potential of gas plasma technology for targeting breast cancer.

Authors:  Sander Bekeschus; Fariba Saadati; Steffen Emmert
Journal:  Clin Transl Med       Date:  2022-08

6.  Toxicity and virucidal activity of a neon-driven micro plasma jet on eukaryotic cells and a coronavirus.

Authors:  Daniel M Mrochen; Lea Miebach; Henry Skowski; Robert Bansemer; Chiara A Drechsler; Ulfilas Hofmanna; Manuel Hein; Uwe Mamat; Torsten Gerling; Ulrich Schaible; Thomas von Woedtke; Sander Bekeschus
Journal:  Free Radic Biol Med       Date:  2022-08-28       Impact factor: 8.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.